Barclays Downgrades Biomea Fusion Stock, Cuts Price Target to $5
Friday, 7 June 2024, 08:57
Biomea Fusion Stock Downgraded by Barclays: Price Target Slashed to $5
In a significant move, Barclays downgraded Biomea Fusion stock and drastically reduced the price target from $30 to $5. This unexpected adjustment reflects a notable shift in the market sentiment towards Biomea Fusion, raising concerns among investors and analysts.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.